News|Videos|August 15, 2025

Allegheny Health Network: Combining Infectious Disease With Critical Care Medicine

The comprehensive program provides instruction in both specialties to enable fellows to treat the most critically ill patients.

We are continuing our new series, Media Day, where we spotlight individual medical institutions and infectious disease (ID) programs. Today, we spotlight the Allegheny Health Network (AHN) in Pittsburgh, Pennsylvania.

AHN’s Nitin Bhanot, MD, MPH, is director of AHN's Division of Infectious Disease and program director of the infectious disease (ID) fellowship program. He noted that one of the unique aspects of the AHN program is that they combine their infectious disease fellowship with critical care medicine.

“There are some commonalities between these two disciplines…. Both deal with multiple organ systems among our patients, and so we thought it would be unique to provide that synergistic combination, where the thought process and cerebral field of infectious disease are combined with procedural skill sets that our critical care medicine physicians have,” Bhanot said. “A lot of patients are in the ICU [intensive care unit] with infections with sepsis and septic shock, and are on antibiotics.... Who else but an ID physician and a critical care physician would be able to [treat] these patients?” Bhanot said.

AHN has a relationship with Lake Erie College of Medicine, Drexel University’s School of Medicine, and Duquesne University. Medical students from Drexel visit AHN for clinical rotations.

Bhanot says AHN’s fellows and trainees get involved in a number of areas.

“We do research in clinical infectious disease, infection prevention, and stewardship—and not just the faculty. We involve our trainees across all levels to be involved in this so that they can also learn how to do QI [quality improvement] projects, how to do research that benefits our patients, which is really the goal of the organization.

Allegheny General Hospital, which is the flagship hospital of AHN, has been recognized as a Center of Excellence by the Infectious Disease Society of America (IDSA). Bhanot explains that it is based on meeting certain metrics in antimicrobial stewardship. IDSA reviews the projects the institutions are doing, and after that analysis and detailed review, IDSA decides whether to offer that accreditation, Bhanot explained.

Look for the next episode when Cassandra Oehler, MD, talks about HIV clinical care at AHN, ongoing research around this subject, and how clinicians are using long-acting injectables.


Related to this article

IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
Staphylococcus aureus Bacteremia (SAB) causes significant morbidity and globally is the leading cause of death from bloodstream infection. This month, the IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. Here is a closer look at Consensus Statement 2: Follow-up Blood Cultures.
Measles Update: September 25, 2026
The latest CDC numbers show a 5.4% increase of measles cases from week-to-week. This year has already become the worst for the number of measles cases in the US since the disease was declared eliminated in 2000. With the start of respiratory virus season, case numbers are expected to continue to increase significantly.